Xenotransplantation of Human Ovarian Tissue Pieces in Gonadotropin-stimulated SCID Mice: The Effect of Ovariectomy

Transcription

1 Xenotransplantation of Human Ovarian Tissue Pieces in Gonadotropin-stimulated SCID Mice: The Effect of Ovariectomy THEODOROS MALTARIS 1, HEINZ KOELBL 1, FRANZ FISCHL 1, RUDOLF SEUFERT 1, MARKUS SCHMIDT 1, JOACHIM KOHL 2, MATTHIAS W. BECKMANN 3, HELGE BINDER 3, INGE HOFFMANN 3, ANDREAS MUELLER 3 and RALF DITTRICH 3 1 Department of Obstetrics and Gynecology, Johannes Gutenberg University, D Mainz; 2 Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, D Frankfurt; 3 Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, D Erlangen, Germany Abstract. The number of follicles were compared in different developmental stages after the cryopreservation of human ovarian tissue by open freezing system followed by xenotransplantation into severe combined immunodeficient (SCID)-mice under stimulation, with and without ovariectomy. Ovarian tissue, cryopreserved for fertility preservation was partly examined by LIVE/DEAD viability staining or was transplanted in the neck muscle of 32 SCID-mice. The development of follicles, estradiol production, vaginal cytology and uterus weight was assessed after 15 weeks under gonadotropin stimulation, with or without ovariectomy. Viable follicles were detected in all frozen/thawed specimens using the LIVE/DEAD assay. Ovariectomy caused a significant improvement of survival of follicles in the preantral and antral stages in the gonadotropin-stimulated animals (p<0.001), whereas there was no significant effect on the primordial and primary follicle counts. In the non-ovariectomised group, only isolated primordial and primary follicles could be detected. The total follicle amount was significantly higher in the ovariectomised group (n=17, 9.2±7.8, mean±sd) than in the non-ovariectomized group (n=15, 0.3±1.0). This study demonstrates that ovariectomy of stimulated recipient SCIDmice is essential for the development of follicles after xenotransplantation of cryopreserved human ovarian grafts. Correspondence to: Theodoros Maltaris, MD, Department of Obstetrics and Gynecology, Mainz University Hospital, Langenbeckstrasse 1, Mainz, Germany. Tel: , Fax: , maltaris@uni-mainz.de Key Words: Cryopreservation, gonadotropin stimulation, ovarian tissue, primordial follicle, xenotransplantation, cancer, fertility preservation. Progress in the treatment of oncological diseases has resulted in the last years to a great improvement of the survival prognosis, especially in children and juvenile cancer patients (1). In the USA alone, more than 20,000 children and young people of reproductive age are exposed every year to known mutagens in the form of chemo- and/or radiotherapy for cancer. In the developed or Westernised countries, women utilise better methods of contraception and delay childbearing for social or financial reasons; as a result an increasing number of women are anxious to preserve their fertility, when their early-stage cancers are discovered. A rising number of patients with non-malignant auto-immune diseases, such as rheumatoid arthritis or systemic lupus and haematological diseases are treated successfully with chemotherapy or radiation (2, 3). One of the serious side-effects of cytotoxic therapies (chemo and/or radio therapy) is the threatening partial or complete destruction of the gonadal function (3). Quality-oflife is increasingly important to long-term survivors of cancer and one of the major quality-of-life issues is the ability to produce and raise normal children. In a recent survey, 72% of women with a breast cancer diagnosis have been reported to discuss fertility concerns with their doctors; 51% felt their concerns were addressed adequately (4). One of the most promising methods for fertility preservation is the cryopreservation of ovarian tissue before oncological treatments because of the large number of follicles that survive the frozen/thawing procedure (5, 6). The problem that arises after the cryopreservation is how to use this frozen material in order to achieve a pregnancy. The vast majority of follicles that survive cryopreservation are primordial (7-10). There are three ways to achieve the development of these follicles to maturity. The first method is autografting, either /2006 $

2 Table I. Follicular development (mean±sd) of SCID-mice (ovarectomised or not) after transplantation of cryopreserved human ovarian tissue from 6 patients under stimulation. Stgr: Indication (age) nscid Ovariec. hmg Primordial Primary Pre-antral Antral 1 Hodgkin (24) 4 x x 4± ± ±2 4.3±2.5 1 CML (10) 5 x x 0.2± ±0.8 6± ±1.8 1 Hodgkin (34) 3 x x ±2 4.3±4.9 1 Ewing sarc. (16) 5 x x 0 0.4± ±0.9 1±1 2 Hodgkin (17) 9 - x 0.1± ± Ovar. Ca. (29) 6 - x Stgr = study groups; ovariec = ovariectomized; hmg = human menopausal gonadotropin. orthotopic, which recently yielded the first human pregnancy after cryopreservation of ovarian tissue (11, 12), or heterotopic, e.g. subcutaneously, in the forearm (13). The latter method necessitates the use of in vitro fertilization (IVF) in order to achieve pregnancy. The second option is the in vitro follicular maturation and IVF, a method which has already yielded pregnancies in animal experiments (14). This method is not applicable to the human species because of the long time period necessary for the primordial follicle to reach the maturation stage (15). The third method is the xenografting of human ovarian tissue in immunodeficient animals [severe compined immonodeficient (SCID)-mice] and their stimulation to full follicular maturation (16-20). Although only two pregnancies have been achieved to date, the cryopreservation of ovarian tissue is offered by many groups due to its future therapeutic potential. The aim of our study was to examine the effect of ovariectomy in stimulated SCID-mice on the development of follicles after xenotransplantation of cryopreserved human ovarian grafts. The survival of the tissue after thawing was examined by the fluorescent LIVE/DEAD viability assay and follicular development was examined after transplantation into SCID-mice. Materials and Methods Animals. Thirty-two female SCID mice (C.B-17/IcrHanHsd scid, 6 weeks of age) were obtained from Harlan-Winkelmann (Borchen, Germany). The animals were housed in a high efficiency particulate air-filtered positive pressure room. Cages (Techniplast, Milano, Italy) were filter topped and animals had free access to food (Altromin 1314, Altromin, Lage, Germany) and water, under 12-h light and 12-h darkness conditions. Groups of 5-9 mice were housed in one cage. Upon arrival from the breeding company, the mice were allowed to get acclimated for one week. All procedures, tests and injections were performed under a laminar flow hood in a positive pressure room. Approval for the study was obtained from the local ethics committee on animal experiments. The animals were maintained in accordance with Animal Care and Use Committee regulations. Patients. Six patients between 10 and 34 (median 20.5) years of age were included in this study, following informed consent and approval of the local university ethical committee. All patients suffered from malignant diseases (Table I) and wanted to preserve ovarian tissue for a future pregnancy. A maximum of 5% of frozen tissue from each patient was used for our experiments. Prior to cryopreservation, a histological examination of the ovarian cortex was performed in order to secure a sufficient amount of primordial follicles. All patients had age-related normal follicular distribution. Cryopreservation protocol. The ovarian cortex was obtained through an operative laparoscopy by dissecting an area of about 20x10x3 mm ovarian tissue antimesenterically. The biopsies were cut into small pieces (approximately 1x1x1 mm) and were equilibrated in ascending aequimolar concentrations of dimethyl sulfoxide (DMSO)/ propandiol up to a concentration of 1.5 M in stages of 0.25 M. The tissue pieces remained in each concentration at 37ÆC for 7 min and at the last concentration of 1.5 M for 30 min. The tissue was then placed in special cryovials (CTE, Erlangen, Germany) and was loaded into an open freezing system which provides self seeding (CTE). The freezing protocol was as follows: a) cool at 5ÆC/min to 3.8ÆC; b) cool at 1ÆC to 5.3ÆC; c) cool at 0.2ÆC to 6ÆC; d) unchanged for 20 min; e) cool at 0.3ÆC to 30ÆC; f) cool at 0.1ÆC to 35ÆC; g) cool at 0.3ÆC to 80ÆC; h) cool at 10ÆC to 110ÆC; and i) immersion in liquid nitrogen. After storage in liquid nitrogen for at least 1 month, the probes were thawed at room temperature. Removal of the cryoprotectant was done in reverse order of the freezing equilibration procedure. The tissue blocks were then cultured in an antibiotic supplemented Medicult IVF-Medium (Gück, Berlin, Germany). Transplantation procedure. Surgery was performed under narcosis with ketamin (80 mg/kg bodyweight, Ketavet, Pharmacia & Upjohn, Erlangen, Germany) and xylazin (10 mg/kg bodyweight, Rompun, Bayer, Frankfurt, Germany), irrespective of the stage of the oestrus cycle. During surgery, mice were kept on a warming plate, the incision site was disinfected with pure alcohol and covered with a one way sterile towel. Both ovaries were removed by a small body wall incision which was sutured with absorbable thread. Xenografting of ovarian cortex was performed within 2 h after removal from the patient to minimize ischemic damage. The ovarian tissue pieces were placed in an intramuscular pocket of the neck muscle. Gonadotropin stimulation. Mice received daily i.p. injections of human menopausal gonadotropin (hmg, Menogon, Ferring, Kiel; 1 IU FSH / 1 IU LH per animal/day) or saline, starting from day 14 after transplantation for 15 weeks. 4172

3 Maltaris et al: Cancer and Fertility Preservation Table II. Pre-freeze follicular count (per mm 2 of ovarian cortex) and survival of follicles assessed with the LIVE/DEAD viability assay after thawing. Patient diagnosis Age Follicular count Survival count (%) mean number/mm 2 (percentage of primordial) Complete Oocyte + Oocyte + Dead follicle >50% granulosa <50% granulosa CML (100%) 31 (41%) 35 (47%) 8 (11%) 1 (1.3%) Ewing sarcoma (97%) 15 (39%) 16 (42%) 7 (19%) 0 Hodgkin (100% ) 28 (45%) 27 (44 %) 7 (11%) 0 Hodgkin (95.7%) 17 (42.5%) 15 (37.5%) 8 (20%) 0 Ovarian-CA (95%) 11 (44%) 11 (44%) 2 (8%) 0 Hodgkin 34 9 (88%) 10 (45%) 9 (41%) 2 (9%) 1 (5%) Table III. Follicle development (mean±sd) in the different study groups. Stgr. nscid Ovariec. hmg Primordial Primary Pre-antral Antral 1 17 x x 1.0± ± ±3.0* 3.3±2.6* x 0.1± ±1.2 0* 0* *Significantly different; stgr = study group; ovariec = ovariectomized; hmg = human menopausal gonadotropin. Oestrus cycle stage determination. Vaginal smears were taken once a week from all mice starting at day 10 after transplantation using sterile pipettes, in order to examine if follicular tissue survived the transplantation and could produce enough oestrogens to cornify the vaginal epithelium. Vaginal cells were left to dry after being smeared on a microscopic slide and were then stained with methylene blue. The epithelium cells were classified into one of the four following categories: a) pro-estrous, b) estrous, c) metestrous, d) diestrous (21). LIVE/DEAD assay. One ovarian tissue piece from each patient was examined for vitality estimation. A fluorescence stain was used to estimate the number of follicles that had survived the freezing/thawing procedure in vitro. The LIVE/DEAD viability/cytotoxicity assay kit (L-3224, Molecular Probes, Leiden, The Netherlands) provides a two-color fluorescence cell viability assay that is based on simultaneous determination of alive and dead cells. The method has been described elsewhere (17). In brief, the tissue was digested in PBS-medium supplemented with 1 mg/ml collagenase (Collagenase Type IV, Sigma-Aldrich, Steinheim, Germany) and incubated at 37ÆC for 2 h. The samples were stained according to the assay instructions and were subsequently examined under a Zeiss fluorescence microscope (IM 35, Zeiss, Oberkochen, Germany). The follicles were classified into 4 categories depending on the percentage of dead granulosa cells (Table II), and were considered dead, only when both the oocyte and all the granulosa cells were dead. Microscopic evaluation of the number of follicles. The grafts were recovered by a skin and neck muscle incision and were fixed in formalin. After routine paraffin embedding, the samples were serially sectioned (3 Ìm) and every tenth section was stained with haematoxylin and eosin and examined microscopically as a reference section. The numbers of primordial, primary, pre-antral and antral Figure 1. Histological staining of a primary follicle (x 250) after cryopreservation and grafting of human ovarian cortex in the SCID mouse. follicles that had survived the transplantation procedure (intact and with ooplasm) were examined. The diameter of the nucleolus of primordial follicles was estimated to be 2 Ìm (17). Using a section thickness of 3 Ìm reduces the risk of overcounting, without totally eliminating it. The follicles were classified as follows: primordial follicles with one layer of flattened granulosa cells surrounding the oocyte; primary follicles with one layer of cuboid granulosa cells; preantral follicles with two or more layers of granulosa cells, but no antrum; and antral follicles with an antral cavity. 4173

4 Statistical evaluation. SPSS was used for data evaluation. Nominal data were expressed as mean±sd and compared using the Student s t-test. A p-value of 0.05 was considered statistically significant. Results The distribution of the ovarian tissue from the 6 patients in the two study groups, the follicular development and uterus weight (mean±sd) are presented in Table I. The pre-freeze histological follicle count and the survival of follicles with the LIVE/DEAD assay after thawing are provided in Table II. The follicular development and the uterus weights in the study groups, as well as the statistical analysis of the results are presented in Table III. Analysis of vaginal smears. Both study groups showed changes in vaginal cytology characteristics of oestrus cycles at days after surgery. These changes were evident through the presence of cornified epithelial cells. Pre-freeze follicular histological count and follicular viability after thawing assessed with the LIVE/DEAD assay. All patients showed age-related normal follicular counts (Table II), and were within 2 orders of standard deviation except the pre-pubertal patient. The primordial follicle was the most predominant follicle type. The results of the fluorescence staining are also given in Table II. Dead follicles were very rare. Follicular survival and development. The results of the follicular count per patient are shown in Table I. Table III shows the results of the follicular count in the various study groups. Ovariectomy caused significant development of follicles in the pre-antral and antral stages in the gonadotropin-stimulated animals (p<0.001), whereas there was no significant effect on the primordial and primary follicle counts (Figure 1). In the nonovariectomised group, only isolated primordial and primary follicles could be detected. The total follicle amount was significantly higher in the ovariectomised group (n=17, 9.2±7.8, mean±sd) than in the nonovariectomised group (n=15, 0.3±1.0). Discussion It is estimated that by 2010, one in every 250 women of reproductive age worldwide will be a cancer survivor (22). However, the lifesaving treatments administered can provoke early menopause and subsequent infertility, due to the destruction of a significant proportion of ovarian follicles by chemo- and radiotherapy. Methods to preserve fertility in these young patients are chemoprotection with GnRHanalogs (23) before the planned chemotherapy, ovarian transposition before radiation and the cryopreservation of cells or ovarian tissue. In April 2004, the first pregnancy after autotransplantation of cryopreserved ovarian tissue was announced by a team of Belgian scientists (11). Many groups are cryopreserving ovarian tissue for future clinical use (1). The aim of the study was to examine the effect of ovarectomy on the number of follicles in different developmental stages of cryopreserved human ovarian grafts transplanted to gonadotropin-stimulated SCID-mice. A slow freezing protocol was used with cryoprotective agents and an open freezing system was already successfully applied for the cleavage stage embryos (24). Many study groups have been using slow freezing equilibrium protocols for the ovarian tissue cryobanking (summarized in 25). The pre-freezing histological follicular count showed normal age-related follicular distribution in the ovary and was in accordance with findings of other studies (26, 27). After thawing, we performed a LIVE/DEAD assay, xenotransplanted the tissue in SCID-mice and tested the viability of the transplanted ovarian tissue by vaginal cytology, uterus weight and follicle count. The cornifying of the epithelial cells of the vaginal mucosa demonstrated that both groups produced ovarian steroid hormones. The results of the staining with the LIVE/DEAD florescent assay confirm that a high percentage of oocytes, as well as granulosa cells survived the cryopreservation and thawing procedure. Our results are in accordance with those of other publications (27, 28). It is known from other studies that the main reason for the follicular loss after cryopreservation and xenografting is the ischaemic effect after transplantation rather than the cryopreservation (29). The following factors influenced the follicular distribution in transplantation studies: the inhomogeneous distribution of follicles in the ovarian cortex (intra-patient variation) (26), the age-related decline of follicles, the inter-patient variation and the size of the grafts (7). Most researchers use human gonadotropins to maximise follicular development in the xenografted ovarian tissue (30, 31). We also stimulated the SCID mice with exogenous gonadotropins in order to promote the development of primordial follicles. Our results indicate that ovariectomy improved the survival of follicles in all developmental stages in the xenotransplanted grafts in the gonadotropin-stimulated SCID mice. Since the stimulation was initiated two weeks after the ovarian transplantation, we assumed that high gonadotropin levels are necessary in the neovascularisation period directly after grafting, which is in accordance with the work of Dissen et al. (32). 4174

5 Maltaris et al: Cancer and Fertility Preservation Since the serum gonadotropins regulate the female reproductive system and are essential for the cyclic growth of follicles after the onset of antrum formation (33), it has been assumed that one effect mediated by these hormones could be the local activation of angiogenic factors in developing follicles and corpora lutea (34, 35). Bex and Goldman (36) were able to show that in bilaterally ovariectomised hamsters, both serum LH and FSH concentrations were significantly elevated when compared with unmanipulated animals. Laschke et al. demonstrated by direct in vivo observation that in ovarectomised hamsters, ovarian graft (although not cryopreserved) vascularisation was not only accelerated but also markedly enhanced (37). In conclusion, the xenotransplantation of small pieces of frozen/thawed human ovarian tissue in SCID mice provides a practical method to assess the development potential of stored ovarian tissue. The observation of even a few growing follicles is sufficient for this purpose, since almost only primordial follicles survive the cryopreservation. Ovariectomy of the mice improves the success of the xenotransplantation procedure as a diagnostic method. Acknowledgements This work was partly supported by the Johannes and Frieda Marohn Foundation, Erlangen, Germany. References 1 Maltaris T, Boehm D, Dittrich R, Seufert R and Koelbl H: Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol, 2006 [Epub ahead of print]. 2 Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H and Dittrich R: The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol, 2006 [Epub ahead of print]. 3 Maltaris T, Koelbl H, Seufert R, Kiesewetter F, Beckmann MW, Mueller A and Dittrich R: Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 8: , Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A and Winer EP: Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22: , Aubard Y, Poirot C, Piver P, Galinat S and Teissier MP: Are there indications for ovarian tissue cryopreservation? Fertil Steril 76: , Liu HC, He Z and Rosenwaks Z: Mouse ovarian tissue cryopreservation has only a minor effect on in vitro follicular maturation and gene expression. J Assist Reprod Genet 20: , Broecke Van den R, Liu J, Handyside A, Van der Elst JC, Krausz T, Dhont M, Winston RM and Hovatta O: Follicular growth in fresh and cryopreserved human ovarian cortical grafts transplanted to immunodeficient mice. Eur J Obstet Gynecol Reprod Biol 97: , Candy CJ, Wood MJ and Whittingham DG: Effect of cryoprotectants on the survival of follicles in frozen mouse ovaries. J Reprod Fertil 110: 11-19, Gook DA, Edgar DH and Stern C: Effect of cooling rate and dehydration regimen on the histological appearance of human ovarian cortex following cryopreservation in 1, 2-propanediol. Hum Reprod 14: , Newton H, Aubard Y, Rutherford A, Sharma V and Gosden R: Low temperature storage and grafting of human ovarian tissue. Hum Reprod 11: , Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B and van Langendonckt A: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: , Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E and Dor J: Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353: , Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M and Rosenwaks Z: Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363: , Eppig JJ and O'Brien MJ: Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 54: , Gougeon A: Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1: 81-87, Maltaris T, Dimmler A, Muller A, Binder H, Hoffmann I, Kohl J, Siebzehnrubl E, Beckmann MW and Dittrich R: The use of an open-freezing system with self-seeding for cryopreservation of mouse ovarian tissue. Reprod Domest Anim 40: , Maltaris T, Kaya H, Hoffmann I, Mueller A, Beckmann MW and Dittrich R: Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue. In Vivo 20: 11-16, Maltaris T, Beckmann MW, Mueller A, Hoffmann I, Kohl J and Dittrich R: Significant loss of primordial follicles after prolonged gonadotropin stimulation in xenografts of cryopreserved human ovarian tissue in severe combined immunodeficient mice. Fertil Steril, 2006 [in press]. 19 Maltaris T, Dragonas C, Hoffmann I, Mueller A, Beckmann MW and Dittrich R: Simple prediction of the survival of follicles in cryopreserved human ovarian tissue. J Reprod Dev 52: , Mueller A, Maltaris T, Dimmler A, Hoffmann I, Beckmann MW and Dittrich R: Development of sex cord stromal tumors after heterotopic transplantation of cryopreserved ovarian tissue in rats. Anticancer Res 25: , Gunasena KT, Villines PM, Critser ES and Critser JK: Live births after autologous transplant of cryopreserved mouse ovaries. Hum Reprod 12: , Blatt J: Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol 33: 29-33, Blumenfeld Z: Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol 15: , Siebzehnruebl ER, Todorow S, van Uem J, Koch R, Wildt L and Lang N: Cryopreservation of human and rabbit oocytes and one-cell embryos: a comparison of DMSO and propandiol. Hum Reprod 4: ,

6 25 Picton HM, Gosden RG and Leibo SP: Cryopreservation of oocytes and ovarian tissue. In: Current Practise and Controversies in Assisted Reproduction. Vayena E, Rowe P, Griffin PD (eds.). Geneva, World Health Organization, pp , Schmidt KL, Byskov AG, Nyboe Andersen A, Muller J and Yding Andersen C: Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod 18: , Siebzehnrubl E, Kohl J, Dittrich R and and Wildt L: Freezing of human ovarian tissue-not the oocytes but the granulosa is the problem. Mol Cell Endocrinol 169: , Martinez-Madrid B, Dolmans MM, Van Langendonckt A, Defrere S and Donnez J: Freeze-thawing intact human ovary with its vascular pedicle with a passive cooling device. Fertil Steril 82: , Liu J, Van der Elst J, Van den Broecke R and Dhont M: Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod 17: , Gook DA, McCully BA, Edgar DH and McBain JC: Development of antral follicles in human cryopreserved ovarian tissue following xenografting. Hum Reprod 16: , Oktay K, Newton H, Mullan J and Gosden RG: Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod 13: , Dissen GA, Lara HE, Fahrenbach WH, Costa ME and Ojeda SR: Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology 134: , Kumar TR, Wang Y, Lu N and Matzuk MM: Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15: , Makris A, Ryan KJ, Yasumizu T, Hill CL and Zetter BR: The nonluteal porcine ovary as a source of angiogenic activity. Endocrinology 115: , Gospodarowicz D, Cheng J, Lui GM, Baird A, Esch F and Bohlen P: Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 117: , Bex FJ and Goldman BD: Serum gonadotropins and follicular development in the Syrian hamster. Endocrinology 96: , Laschke MW, Menger MD and Vollmar B: Ovariectomy improves neovascularization and microcirculation of freely transplanted ovarian follicles. J Endocrinol 172: , Received September 28, 2006 Accepted October 18,